US EditionA type of gastric balloon, considered too risky, has been withdrawn from the market in France
9 Articles
9 Articles
Health authorities in France have called for the immediate withdrawal from the French market of the anti-obesity gastric balloon from start-up Allurion, which promises to help lose weight without surgery but which risks causing serious complications, AFP quoted by Agerpres wrote.
The uncertain effectiveness and the undesirable effects of this device aimed at promoting weight loss have led the French health authorities to suspend its marketing.
At the beginning of July, the Medicines and Healthcare products Regulatory Agency issued a safety alert for patients using these gastric balloons.
The gastric balloon from the start-up Allurion, several thousand copies of which are implanted each year, has just been withdrawn from the market by the French health authorities
French health authorities demanded on Tuesday the immediate withdrawal of the anti-obesity gastric balloon from the market of start-up Allurion, which promises to help lose weight without requiring surgery but can cause serious complications.
French authorities have called for the urgent withdrawal from the French market of the Allurion anti-obesity gastric balloon because it can cause serious complications such as intestinal obstruction.
Coverage Details
Bias Distribution
- 67% of the sources lean Left
To view factuality data please Upgrade to Premium
